Concepedia

Author

Stephen Mackinnon

University College LondonORCID

Also Known As

Eleni Tholouli, MACKINNON, S, MacKinnon, S, MacKinnon, Stephen, Mackinnon Stephen, Mackinnon, S, RC Harvey, S MacKinnon, S Mackinnon, S. MacKinnon

375

Publications

14.8K

Citations

63

H-Index

100

Concepts

All Affiliations

University College LondonThe Royal Free HospitalUniversity College HospitalRoyal London HospitalHeartlands Hospital
SM

About

Stephen Mackinnon is an author at University College London specializing in medicine, transplantation, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

32

52

3.3K

2

Blood Transplantation

18

18

1.3K

3

Cell Biology

11

11

605

4

Health Sciences

9

9

780

5

Cellular Physiology

1

1

16

Stephen Mackinnon

×

135

Publications

13.4K

Citations

60

H-Index

YearCitations

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

Esperanza B. Papadopoulos, Marc Ladanyi, David Emanuel,

New England Journal of Medicine

1994

1.1K

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

Stephen Mackinnon, EB Papadopoulos, MH Carabasi,

Blood

1995

749

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Panagiotis Kottaridis, Donald Milligan, Rajesh Chopra,

Blood

2000

502

Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions

TN Small, Esperanza B. Papadopoulos, Farid Boulad,

Blood

1999

484

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines

Karl S. Peggs, Stephanie Verfuerth, Arnold Pizzey,

The Lancet

2003

456

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

Stephen Robinson, Anthony H. Goldstone, Stephen Mackinnon,

Blood

2002

387

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra,

Blood

2002

359

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

Ronjon Chakraverty, Karl S. Peggs, Rajesh Chopra,

Blood

2002

344

Specific human cellular immunity to bcr-abl oncogene-derived peptides

Monica Bocchia, Tatyana Korontsvit, Qin Xu,

Blood

1996

289

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Emma Morris, Kirsty Thomson, Charles Craddock,

Blood

2004

288

Page 1